Salt Pharma

An important part of Salt Investments’ portfolio is its holding in Actavis Group, a company with a leading global presence in the development, manufacture, and sale of first-class generic pharmaceuticals. Founded in 1956, the Actavis has led an assertive programme of expansion, making more than 30 acquisitions in the past seven years while maintaining strong organic growth. The Group has approximately 11,000 employees operating in over 40 countries around the globe.